Pavblu 40 mg/ml
Pavblu 40 mg/ml is a medicine authorised by Swissmedic under authorisation number 69763. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 June 2025 and the authorisation is limited until 16 June 2030. ATC code S01LA05 places the medicine in the group Ophthalmologicals.
| Authorisation number | 69763 |
|---|---|
| Name | Pavblu 40 mg/ml |
| Full name | Pavblu 40 mg/ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Amgen Switzerland AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01LA05 |
| First authorisation | 17 June 2025 |
| Authorisation validity | 16 June 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pavblu 40 mg/ml, Injektionslösung in einer Fertigspritze | B | 17 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Spritze(n) | S01LA05 | 11.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pavblu 40 mg/ml authorised in Switzerland?
Yes. Pavblu 40 mg/ml is authorised by Swissmedic under authorisation number 69763, data as of 01 September 2026. The authorisation is limited until 16 June 2030.
Which dispensing category does Pavblu 40 mg/ml have?
Pavblu 40 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pavblu 40 mg/ml?
The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.